AstraZeneca to launch new cancer drugs line

AstraZeneca has launched a new production line at its Kaluga Region plant to manufacture innovative oncology drugs, including targeted treatments for cancers linked to BRCA1/2 gene mutations. The facility uses advanced sealed technology for handling potent substances and will produce two full-cycle targeted cancer drugs.